High-resolution microscopic images of T cells that have been engineered with TGF-beta SNIPRs (shown in red) as they bind to TGF-beta (shown in green). The SNIPRs activate once the receptors fold into ...
A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...
Israeli and international scientists have uncovered a surprising way that melanoma, the deadliest form of skin cancer, ...
A single dose of Immutep’s MS therapy, IMP761, was well tolerated and reduced T-cell activity for up to 23 days in healthy ...
A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...
Researchers at the Massachusetts Institute of Technology and Stanford University have reported a novel immunotherapy strategy ...
Immunotherapy has transformed healthcare and how physicians treat patients. Various forms of immunotherapy have been ...
Researchers at the University of Sharjah are exploring a promising approach that could enhance the immune system's ability to ...
Scientists showed that using new molecules that block an immune "checkpoint" could stimulate a "strong" anti-tumor immune ...
Most cancer treatments – from chemotherapies to engineered immune cells – have a host of side effects, in large part because they affect healthy cells in the body at the same time as targeting tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback